Thrombolytic and Anticoagulant Therapy for Pulmonary Embolism with High and Intermendiate Risk of Early Death. Part 3. An Effect on Pulmonary Perfusion with High and Intermediate Risk of Early Death

Background The advantage of thrombolytic therapy (TLT) over anticoagulant therapy(ACT) in patients with a high risk of early death (hemodynamic disorders) in acute pulmonary embolism is considered proven. But the advantage of thrombolytic therapy over anticoagulant therapy remains uncertain in patie...

Descrizione completa

Dettagli Bibliografici

Autori principali:	O. V. Nikitina, I. P. Mikhailov, N. Y. Kudryashova, E. V. Migunova, A. G. Dorfman, V. I. Avfukov
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department 2018-11-01
Serie:	Неотложная медицинская помощь
Soggetti:	pulmonary embolism thrombolytic therapy anticoagulant therapy perfusion scintigraphy pulmonary perfusion deficiency pulmonary hypertension intermediate risk of early death
Accesso online:	https://www.jnmp.ru/jour/article/view/501
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!